• 833–88CLOUD (2-5683)



CloudPeak Nutrition’s RESOLITROL® is produced at an FDA certified GMP (Good Manufacturing Practices) facility. We only utilize the highest purity and quality ingredients in CloudPeak Nutrition’s products to further ensure product safety and efficacy for our consumers.

As with every dietary supplement, you should first consult with your physician prior to taking RESOLITROL®. Keep out of reach of children. Pregnant or nursing mothers, individuals under 18 or individuals with a suspected or known medical condition should consult their doctor.

What are the ingredients in RESOLITROL®?
RESOLITROL® is an all-natural, patented high purity blend of 100 mg of ursolic acid from Rosemary extract and 200 mg of trans-resveratrol from Polygonum cuspidatum (also referred to as Japanese knotweed). We use vegetarian friendly capsules derived from plant cellulose and a minimal amount of rice flour (to ensure proper filing of our veggie-capsule).
What are the benefits of taking RESOLITROL® daily?

RESOLITROL® is a unique multi-faceted formula that provides your body with numerous health benefits when used in conjunction with a healthy diet and exercise routine.

RESOLITROL® has been clinically researched to be up to 14 times more effective in order to provide your body optimal support with:

  • † Healthy Immune System
  • † Helps Promote Weight Loss & Lean Muscle
  • † Helps Maintain Already Healthy Blood Sugar Levels
  • † Healthy Joints & Mobility
  • † Promotes Calmness And Relaxation
  • † For Relief Of Occasional Sleeplessness
How do I take RESOLITROL®?

The suggested use for RESOLITROL® is one (1) veggie capsule per day. You may take up to three (3) capsules within a 24 hour period. RESOLITOROL® is best consumed with meals.

As with every dietary supplement, you should first consult with your physician prior to taking RESOLITROL®. Keep out of reach of children. Pregnant or nursing mothers, individuals under 18 or individuals with a suspected or known medical condition should consult their doctor.
Where is RESOLITROL® manufactured?
CloudPeak Nutrition’s products are manufactured and bottled in the USA. Our ingredient raw materials are sourced from around the world and every ingredient and finished products are tested and verified by 3rd party labs.
Where can I purchase RESOLITROL®?

RESOLITROL® can be purchased online at Amazon or RESOLITROL.com


For more information please visit pubmed.gov

  1. Junco JJ, Mancha A, Malik G, et al. Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid. Mol Cancer Res. 2013;11(12):1521-1529. doi:10.1158/1541-7786.MCR-13-0237
  2. Cho J, Rho O, Junco J, et al. Effect of Combined Treatment with Ursolic Acid and Resveratrol on Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate. Cancer Prev Res (Phila). 2015;8(9):817-825. doi:10.1158/1940-6207.CAPR-15-0098
  3. Lodi A, Saha A, Lu X, et al. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism [published correction appears in NPJ Precis Oncol. 2017 Sep 4;1(1):30]. NPJ Precis Oncol. 2017;1:18. doi:10.1038/s41698-017-0024-z
  4. Brasnyó P, Molnár GA, Mohás M, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106(3):383-389. doi:10.1017/S0007114511000316
  5. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612-622. doi:10.1016/j.cmet.2011.10.002
  6. Howells LM, Berry DP, Elliott PJ, et al. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila). 2011;4(9):1419-1425. doi:10.1158/1940-6207.CAPR-11-0148
  7. Patel KR, Brown VA, Jones DJ, et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010;70(19):7392-7399. doi:10.1158/0008-5472.CAN-10-2027
  8. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337-342. doi:10.1038/nature05354
  9. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127(6):1109-1122. doi:10.1016/j.cell.2006.11.013
  10. Park SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148(3):421-433. doi:10.1016/j.cell.2012.01.017
  11. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275(5297):218-220. doi:10.1126/science.275.5297.218
  12. Tang X, Shi L, Xie N, et al. SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis. Nat Commun. 2017;8(1):318. Published 2017 Aug 22. doi:10.1038/s41467-017-00396-9
  13. Peng L, Jiang D. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition. PLoS One. 2018;13(10):e0205918. Published 2018 Oct 24. doi:10.1371/journal.pone.0205918
  14. Lee H, Zhang P, Herrmann A, et al. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci U S A. 2012;109(20):7765-7769. doi:10.1073/pnas.1205132109
  15. Lissa D, Senovilla L, Rello-Varona S, et al. Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention. Proc Natl Acad Sci U S A. 2014;111(8):3020-3025. doi:10.1073/pnas.1318440111
  16. Ramírez-Rodríguez AM, González-Ortiz M, Martínez-Abundis E, Acuña Ortega N. Effect of Ursolic Acid on Metabolic Syndrome, Insulin Sensitivity, and Inflammation. J Med Food. 2017;20(9):882-886. doi:10.1089/jmf.2017.0003
  17. Qian Z, Wang X, Song Z, et al. A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors. Biomed Res Int. 2015;2015:809714. doi:10.1155/2015/809714
  18. Kunkel SD, Elmore CJ, Bongers KS, et al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One. 2012;7(6):e39332. doi:10.1371/journal.pone.0039332
  19. Ullevig SL, Zhao Q, Zamora D, Asmis R. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis. 2011;219(2):409-416. doi:10.1016/j.atherosclerosis.2011.06.013
  20. Jang SM, Yee ST, Choi J, et al. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int Immunopharmacol. 2009;9(1):113-119. doi:10.1016/j.intimp.2008.10.013
  21. Rao VS, de Melo CL, Queiroz MG, et al. Ursolic acid, a pentacyclic triterpene from Sambucus australis, prevents abdominal adiposity in mice fed a high-fat diet. J Med Food. 2011;14(11):1375-1382. doi:10.1089/jmf.2010.0267
  22. Shanmugam MK, Ong TH, Kumar AP, et al. Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS One. 2012;7(3):e32476. doi:10.1371/journal.pone.0032476
  23. Gao N, Cheng S, Budhraja A, et al. Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway. Br J Pharmacol. 2012;165(6):1813-1826. doi:10.1111/j.1476-5381.2011.01684.x
  24. Junco JJ, Cho J, Mancha A, et al. Role of AMPK and PPARα in the anti-skin cancer effects of ursolic acid. Mol Carcinog. 2018;57(12):1698-1706. doi:10.1002/mc.22890
  25. Brown VA, Patel KR, Viskaduraki M, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010;70(22):9003-9011. doi:10.1158/0008-5472.CAN-10-2364
  26. Zhu Z, Qian Z, Yan Z, Zhao C, Wang H, Ying G. A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors. Int J Nanomedicine. 2013;8:129-136. doi:10.2147/IJN.S38271

FEEL the Difference